Pancreatic cancer pill shows promise in early trial results
A daily pill called daraxonrasib appears to shrink and possibly eliminate tumors in some patients with advanced pancreatic cancer, according to BBC Health. In early medical trials, cancer became undetectable on scans in one in 12 patients who received daraxonrasib along with chemotherapy. Tumors stopped growing in almost all 61 participants who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body.
Experts are calling this the biggest breakthrough in pancreatic cancer treatment for decades, BBC Health reported. Cancer Research UK called it "the biggest leap forward in decades" for pancreatic cancer patients. The charity noted that the drug has found a way to treat a disease that was previously considered very difficult to drug.
Pancreatic cancer is notoriously hard to treat and has the lowest survival rate of all common cancers in the UK, according to BBC Health. Although chemotherapy can shrink tumors somewhat, the cancer often grows again. Most patients with advanced disease survive months, not years.
Doctors stress that it is unclear how long the drug might keep the disease at bay and should not be seen as a cure, BBC Health reported. The trial followed patients for an average of a year and a half. Doctors hope the new treatment might offer patients more time, even if it cannot stop cancers permanently.
What it means in Raleigh
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Partners Health Management, Trillium Health Resources, Vaya Health.
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.